{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gpt-5.2",
  "confidence": 0.9,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3_1_us",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA), Table 1",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added US-only clarification in SoA footnote indicating that certain procedures are specific to screening-only sites as detailed in Section 8"
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3_1_us",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Updated scientific rationale text to align zinc discontinuation timing from 30 days to 21 days"
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3_1_us",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added US-only operational option for certain US sites to perform screening procedures only (no remaining study procedures), to support recruitment and reduce participant burden"
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3_1_us",
        "reasonText": "Clarify study procedures occurring across different sites in the US to facilitate participant recruitment across different regions of the US and to lessen inconvenience for participants without compromising study quality.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3_1_us",
        "reasonText": "Align the number of days after zinc discontinuation referenced in Section 4.2 with the mention of zinc discontinuation elsewhere in the protocol.",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_3_1_us",
        "reasonText": "Add US-only language allowing screening-only sites to support recruitment across different US regions and reduce participant inconvenience without compromising study quality.",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3_1_us",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Addition of text to the footnote to state that procedures specific to screening sites (only in the US) [are] detailed in Section 8.",
        "summary": "Added SoA footnote text cross-referencing Section 8 for US screening-site-specific procedures."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3_1_us",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed zinc washout timing statement from 30 days to 21 days."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3_1_us",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added US-only operational procedure allowing certain sites to conduct screening-only activities."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 3,
      "changeCount": 3
    }
  }
}